PINC
Premier, Inc.28.26
+0.00+0%
Nov 25, 4:00:00 PM EST
Earnings Call Transcripts
This Quarter (Q1 '26)
No earnings call transcript available yet
Last Quarter (Q4 '25)
No earnings call transcript available
Key Stats
Market Cap
2.34BP/E (TTM)
166.24Basic EPS (TTM)
0.17Dividend Yield
0.03%Recent Filings
8-K
Premier merger closes at $28.25/share
Premier completed its merger with Patient Square Capital's subsidiary on November 25, 2025, for $28.25 per share in cash—totaling ~$2.4B to equityholders. The deal triggered Nasdaq delisting, full repayment of its credit agreement, and board overhaul, with Michael Alkire and Glenn Coleman now directing the private entity. Public shareholders cashed out.
8-K
Stockholders approve $28.25/share merger
Premier stockholders overwhelmingly approved the merger with Patient Square Capital's affiliate on November 21, 2025, with 99% of voted shares—79% of outstanding—in favor. The deal, signed September 21, offers $28.25 cash per share. Closing awaits customary conditions around November 25. Regulatory approvals remain key.
8-K
Proxy supplemented amid suits
Premier supplemented its merger proxy with detailed management forecasts showing revenue climbing from $955M in FY2026 to $1,603M in FY2039 and unlevered FCF reaching $229M, plus added fairness opinion details from Goldman Sachs and BofA. Three stockholder suits claim proxy omissions; Premier denies merit but discloses to avert delays. Risks loom from litigation.
8-K
Q1 revenue dips 3%
Premier reported Q1 FY2026 net revenue of $240M, down 3% year-over-year, with adjusted EBITDA of $55M off 12% but Supply Chain Services holding flat. Net income plunged 79% to $15.3M, stripped of last year's $57M lawsuit gain. Pending Patient Square buyout halts guidance and dividends. Core ops resilient amid Contigo wind-down.
10-Q
Q1 FY2026 results
Premier's Q1 FY2026 net revenue dipped 3% y/y to $240M, with Supply Chain Services flat at $152M while Performance Services fell 9% y/y to $88M on lower software licenses, yet gross profit held at 71% of revenue. Operating income slid to $25M from $35M y/y amid higher costs, but diluted EPS attributable to stockholders landed at $0.21 on 83.6M shares, reconciling cleanly. Cash fell to $43M with $16M operating cash flow, $280M Credit Facility draw steady and $715M available; free cash flow turned negative at -$14M (derived). IllumiCare acquisition closed June 2025 for $46.7M (cash), adding $31M goodwill. Pending Patient Square merger at $28.25/share faces HSR review. Merger delays could disrupt operations.
IPO
Website
Employees
Sector
Industry
BTSG
BrightSpring Health Services, I
36.44+0.48
CMHSF
COMPREHENSIVE HEALTHCARE SYS IN
0.35+0.00
DH
Definitive Healthcare Corp.
2.29-0.01
LGMK
LogicMark, Inc.
0.76+0.00
NEUE
NeueHealth, Inc.
6.75+0.00
PAXH
PreAxia Health Care Payment Sys
0.22+0.00
PHLT
Performant Healthcare, Inc.
7.75+0.00
PIII
P3 Health Partners Inc.
4.59-0.36
PREM
Premier Air Charter Holdings In
0.03-0.01
PRVA
Privia Health Group, Inc.
23.81-0.53